141 related articles for article (PubMed ID: 3701612)
1. Effect of particle dissolution rate on ocular drug bioavailability.
Hui HW; Robinson JR
J Pharm Sci; 1986 Mar; 75(3):280-7. PubMed ID: 3701612
[TBL] [Abstract][Full Text] [Related]
2. General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.
Deng F; Ranta VP; Kidron H; Urtti A
Pharm Res; 2016 Nov; 33(11):2680-90. PubMed ID: 27431864
[TBL] [Abstract][Full Text] [Related]
3. Volume to dissolve applied dose (VDAD) and apparent dissolution rate (ADR): tools to predict in vivo bioavailability from orally applied drug suspensions.
Muenster U; Pelzetter C; Backensfeld T; Ohm A; Kuhlmann T; Mueller H; Lustig K; Keldenich J; Greschat S; Göller AH; Gnoth MJ
Eur J Pharm Biopharm; 2011 Aug; 78(3):522-30. PubMed ID: 21315152
[TBL] [Abstract][Full Text] [Related]
4. Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension.
Le Merdy M; Fan J; Bolger MB; Lukacova V; Spires J; Tsakalozou E; Patel V; Xu L; Stewart S; Chockalingam A; Narayanasamy S; Rouse R; Matta M; Babiskin A; Kozak D; Choi S; Zhang L; Lionberger R; Zhao L
AAPS J; 2019 May; 21(4):65. PubMed ID: 31111305
[TBL] [Abstract][Full Text] [Related]
5. Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits.
Schoenwald RD; Stewart P
J Pharm Sci; 1980 Apr; 69(4):391-4. PubMed ID: 7373531
[TBL] [Abstract][Full Text] [Related]
6. Vehicle effects on ocular drug bioavailability i: evaluation of fluorometholone.
Sieg JW; Robinson JR
J Pharm Sci; 1975 Jun; 64(6):931-6. PubMed ID: 1133744
[TBL] [Abstract][Full Text] [Related]
7. Ophthalmic bioequivalence of steroid/antibiotic combination formulations.
Schoenwald RD; Harris RG; Turner D; Knowles W; Chien DS
Biopharm Drug Dispos; 1987; 8(6):527-48. PubMed ID: 3427210
[TBL] [Abstract][Full Text] [Related]
8. Topical pharmacokinetics of dexamethasone suspensions in the rabbit eye: Bioavailability comparison.
Naageshwaran V; Ranta VP; Toropainen E; Tuomainen M; Gum G; Xie E; Bhoopathy S; Urtti A; Del Amo EM
Int J Pharm; 2022 Mar; 615():121515. PubMed ID: 35091006
[TBL] [Abstract][Full Text] [Related]
9. Ocular pharmacokinetics and availability of topically applied baicalein in rabbits.
Zhang L; Zhang J; Wang L; Xia H
Curr Eye Res; 2009 Apr; 34(4):257-63. PubMed ID: 19373573
[TBL] [Abstract][Full Text] [Related]
10. Biopharmaceutics of Topical Ophthalmic Suspensions: Importance of Viscosity and Particle Size in Ocular Absorption of Indomethacin.
Toropainen E; Fraser-Miller SJ; Novakovic D; Del Amo EM; Vellonen KS; Ruponen M; Viitala T; Korhonen O; Auriola S; Hellinen L; Reinisalo M; Tengvall U; Choi S; Absar M; Strachan C; Urtti A
Pharmaceutics; 2021 Mar; 13(4):. PubMed ID: 33810564
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
[TBL] [Abstract][Full Text] [Related]
12. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
13. Influence of topical anesthesia on tear dynamics and ocular drug bioavailability in albino rabbits.
Patton TF; Robinson JR
J Pharm Sci; 1975 Feb; 64(2):267-71. PubMed ID: 1127583
[TBL] [Abstract][Full Text] [Related]
14. Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits.
Zhang J; Wang L; Gao C; Zhang L; Xia H
J Ocul Pharmacol Ther; 2008 Oct; 24(5):501-6. PubMed ID: 18803444
[TBL] [Abstract][Full Text] [Related]
15. A corneal perfusion device for estimating ocular bioavailability in vitro.
Richman JB; Tang-Liu DD
J Pharm Sci; 1990 Feb; 79(2):153-7. PubMed ID: 2324964
[TBL] [Abstract][Full Text] [Related]
16. Relationship of chemical structure to corneal penetration and influence of low-viscosity solution on ocular bioavailability.
Grass GM; Robinson JR
J Pharm Sci; 1984 Aug; 73(8):1021-7. PubMed ID: 6491903
[TBL] [Abstract][Full Text] [Related]
17. Formulation, in vitro dissolution, and ocular bioavailability of high- and low-melting phenylephrine oxazolidines.
Qiu Y; Guillory JK; Schoenwald RD
Pharm Res; 1993 Nov; 10(11):1627-31. PubMed ID: 8290476
[TBL] [Abstract][Full Text] [Related]
18. Penetration of fluorometholone into the cornea and aqueous humor.
Kupferman A; Leibowitz HM
Arch Ophthalmol; 1975 Jun; 93(6):425-7. PubMed ID: 1131082
[TBL] [Abstract][Full Text] [Related]
19. Corneal absorption of fluorometholone in rabbits. A comparative evaluation of corneal drug transport characteristics in anesthetized and unanesthetized rabbits.
Sieg JW; Robinson JR
Arch Ophthalmol; 1974 Sep; 92(3):240-3. PubMed ID: 4851189
[No Abstract] [Full Text] [Related]
20. Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes.
Patton TF; Robinson JR
J Pharm Sci; 1976 Sep; 65(9):1295-301. PubMed ID: 966141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
